- Ongoing, recruitingPhase II and Phase III (Integrated)
22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis
This study is testing a new medicine, Izokibep, for people with active psoriatic arthritis. We want to see if it helps reduce symptoms and if it's safe compared to a dummy medicine (placebo). It's a big study involving many people.
For: Psoriatic ArthritisHungary · Czechia · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Moderate to Severe Hidradenitis Suppurativa
This study is testing a new medicine, Izokibep, for people with moderate to severe hidradenitis suppurativa (HS). It compares Izokibep to a dummy medicine to see if it improves HS symptoms and is safe.
For: Hidradenitis SuppurativaHungary · France · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior- or Pan-uveitis
This study is testing a new medicine, Izokibep, for people with a type of eye inflammation called uveitis. Researchers want to see if it works better than a dummy treatment to stop the condition from getting worse and how safe it is.
For: Non-infectious · Intermediate- · Posterior- or Pan-uveitisFrance · Czechia · Austria